CRISPR Therapeutics (CRSP) Q3 2026 Earnings

10AugConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
-1.37
-1.3
-1.23
-1.16

Details

Expected EPS
-1.169951
Actual EPS
N/A
Surprise EPS
1.17
Surprise Percent
+100%

Description

CRISPR Therapeutics (CRSP) will report earnings of for Q3 2026 on August 10, 2026.

0 Comments

Share your thoughts